PRESS RELEASE published on 07/18/2024 at 17:56, 4 months 2 days ago Informations privilégiées / Communiqué sur comptes, résultats Median Technologies annonce un carnet de commandes record et les résultats de l'étude eyonis LCS. Chiffre d'affaires semestriel à 10,9 m€, vision et opportunités de croissance en iCRO. Webcast avec le CEO le 24/07/2024 Chiffre D'affaires Carnet De Commandes Median Technologies ICRO Eyonis LCS
BRIEF published on 06/07/2024 at 17:50, 5 months 13 days ago Modifications des droits de vote des actionnaires chez Median Technologies Droit De Vote Partage Le Capital Technologies Médianes Actions Sans Droit De Vote Réglementation Française
BRIEF published on 06/07/2024 at 17:50, 5 months 13 days ago Changes in Shareholder Voting Rights at Median Technologies Share Capital Voting Rights French Regulations Median Technologies Non-voting Shares
PRESS RELEASE published on 06/07/2024 at 17:45, 5 months 13 days ago Modification des droits attachés aux catégories d'actions Déclaration du nombre de droits de vote et d'actions de Median Technologies au 31 mai 2024. Découvrez les chiffres clés de l'entreprise et ses activités dans l'imagerie médicale et l'IA Euronext Growth Imagerie Médicale Intelligence Artificielle Oncologie Median Technologies
PRESS RELEASE published on 06/07/2024 at 17:45, 5 months 13 days ago Changes in the rights attaching to the classes of shares or securities Median Technologies discloses total voting rights and share capital as of May 31, 2024, in compliance with French regulations. The company specializes in AI-driven solutions for cancer diagnosis and treatment Share Capital Voting Rights AI Solutions Median Technologies Cancer Diagnosis
BRIEF published on 05/29/2024 at 17:50, 5 months 22 days ago Median Technologies participera à la réunion annuelle de l'ASCO 2024 à Chicago Solutions D'imagerie Essais Cliniques Oncologie Technologies Médianes Réunion Annuelle De L'ASCO
BRIEF published on 05/29/2024 at 17:50, 5 months 22 days ago Median Technologies to Attend 2024 ASCO Annual Meeting in Chicago Clinical Trials Oncology Imaging Solutions Median Technologies ASCO Annual Meeting
PRESS RELEASE published on 05/29/2024 at 17:45, 5 months 22 days ago Inside Information / Other news releases Median Technologies to participate in the 2024 ASCO Annual Meeting at McCormick Place, Chicago, IL, USA. Abstract on double reading performance in lung clinical trials. Event details and company overview Clinical Trials Oncology Medical Imaging Median Technologies ASCO Annual Meeting
BRIEF published on 05/21/2024 at 17:50, 5 months 30 days ago Median Technologies strengthens its position with pharmaceutical giants Artificial Intelligence Oncology Medical Imaging Median Technologies Clinical Tests
BRIEF published on 05/21/2024 at 17:50, 5 months 30 days ago Median Technologies renforce sa position auprès des géants pharmaceutiques Imagerie Médicale Intelligence Artificielle Essais Cliniques Oncologie Median Technologies
Published on 11/21/2024 at 16:30, 41 minutes ago The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 10 minutes ago Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 11 minutes ago Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 1 hour 11 minutes ago Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 16:00, 1 hour 11 minutes ago Isaac Ullatil Joins Wellstack Board of Directors
Published on 11/21/2024 at 17:01, 10 minutes ago Original-Research: Delticom AG (von Montega AG): Kaufen
Published on 11/21/2024 at 15:41, 1 hour 29 minutes ago Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 06:58, 10 hours 13 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 10 hours 13 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 10 hours 13 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 21 hours 4 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 21 hours 51 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
